logo.jpg
UK Cultivates a $6.1 Billion Agri-Equipment Market by 2028: Sustainability and Tech Drive Growth: Ken Research
May 16, 2024 06:11 ET | Ken Research
Gurugram, India, May 16, 2024 (GLOBE NEWSWIRE) -- The United Kingdom's agricultural landscape is undergoing a transformation! The UK Agri-Equipment Market is projected to reach a robust $6.1 billion...
22157.jpg
Global Live Events Analysis Report 2024-2030 Featuring Live Nation, Anschutz, Cineplex, Cvent, Eventbrite, LiveStyle, Feld Entertainment, Broadway Across America, MSG, & Cirque du Soleil
May 16, 2024 06:09 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Live Events Market (2024 Edition): Analysis By Event Type (Music, Sports, Comedy, and Theater), By Revenue Source, By Age Group, By Region, By...
Alchip Technologies
Alchip Technologies Reports Record Q1 FY2024 Revenue and Net Income
May 16, 2024 06:03 ET | Alchip Technologies
Taipei, Taiwan, May 16, 2024 (GLOBE NEWSWIRE) -- Alchip Technologies has reported record revenue of USD$333.6 million for the first quarter of its 2024 fiscal year, topping first quarter FY2023...
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
May 16, 2024 06:00 ET | HSBC Bank Plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) ...
arvinas_logoART_lg.jpg
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024 06:00 ET | Arvinas Inc.
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in...
BES_Mark.jpg
LANZATECH ALERT: Bragar Eagel & Squire, P.C. Investigates De-SPAC Merger of LNZA and AMCI and Encourages Investors to Contact the Firm
May 16, 2024 06:00 ET | Bragar Eagel & Squire
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into the officers or directors of...
BES_Mark.jpg
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimmick Stockholders and Encourages Investors to Contact the Firm
May 16, 2024 06:00 ET | Bragar Eagel & Squire
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Shimmick Corporation...
SRP_logo_Logo.jpg
South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports
May 16, 2024 06:00 ET | South Rampart Pharma
SRP-001 is a novel, non-opioid new chemical entity without abuse, liver, and kidney toxicities present in current pain medications Publication introduces SRP-001 as a safer alternative to existing...
CRCAM TOULOUSE 31 :
CRCAM TOULOUSE 31 : DESCRIPTIF DU PROGRAMME DE RACHAT DE SES PROPRES CCI - AG DU 28 MARS 2024
May 16, 2024 06:00 ET | CRCAM TOULOUSE 31
CREDIT AGRICOLE TOULOUSE 31 Société coopérative à capital variable, agréée en tant qu’établissement de créditSociété de courtage d’assurance immatriculée auRegistre des...
Picture1 (4).jpg
Macerich Announces Initial Progress in its Path Forward Strategic Plan
May 16, 2024 06:00 ET | Macerich Company
SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced...